ABBEY CLINICAL LIMITED

🌿Early-stageactive
14746822 · ltd · incorporated 2023-03-21
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
book net assets
Opportunity
66/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: General medical practice activities
Sector: Human health & social work
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 66/100 (strong), bankability 60/100. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: Confirmation statement overdue. Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal. Most likely exit: strategic trade sale (73/100).

Data confidence

Overall: medium (76/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
4 officers (4 active, 4 linked, 4 with DOB)
90
Ownership & PSC
4 active PSC(s) of 4 total, 4 with control declared
90
Director network
Network not yet resolved
30
Filing history
5 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
66/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
50
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
67
Some moderate concerns — review flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Mar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2025-03-312024-03-31

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (8 events)Click to expand
  1. 2025-12-31
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  2. 2024-11-15
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  3. 2023-03-21
    🏢
    Company incorporated
    As ABBEY CLINICAL LIMITED
  4. 2023-03-21
    JARWAR, Ghazala appointed
    director
  5. 2023-03-21
    MADDEN, James appointed
    director
  6. 2023-03-21
    SEN, Subir appointed
    director
  7. 2023-03-21
    VAILLANT VILA, Juan Carlos appointed
    director
  8. 2023-03-21
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

55/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • -4 active directors: Broader management team in place — suggests transferable governance.
  • +Founder age: Director aged approximately 68 — succession pressure is live.

Succession & seller-readiness

50/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 68. Approaching typical UK retirement age — succession thinking likely.

Red flags

1 high ·
Confirmation statement overdue
high

Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal.

Evidence: Next due: 2026-04-03

Shareholders & ownership

4 active beneficial owners · fragmented
NameSharesVoting rightsNature of controlNotified
Mr James Madden
Individual · British · DOB 10/1982 · age 44
2550%
25–50%board control25-50% shares · 25-50% voting · board control21/03/2023
Mr Subir Sen
Individual · British · DOB 05/1961 · age 65
2550%
25–50%board control25-50% shares · 25-50% voting · board control21/03/2023
Ms Ghazala Jarwar
Individual · British · DOB 12/1958 · age 68
2550%
25–50%board control25-50% shares · 25-50% voting · board control21/03/2023
Mr Juan Carlos Vaillant Vila
Individual · Spanish · DOB 08/1972 · age 54
2550%
25–50%board control25-50% shares · 25-50% voting · board control21/03/2023

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · HA postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
24/7 DENTAL CLINICS LTD
06672264 · est 2008 · no financials extracted
17y
31 DENTAL LIMITED
14130927 · est 2022 · no financials extracted
3y
313 PARTNERSHIP LIMITED
16189373 · est 2025 · no financials extracted
1y
3W HEALTH LIMITED
16640433 · est 2025 · no financials extracted
5INQ LIMITED
15753834 · est 2024 · no financials extracted
1y
A & B DENTAL LTD
10389697 · est 2016 · no financials extracted
9y
A&A HEALTH LTD
15379222 · est 2023 · no financials extracted
2y
AASHRAY CARE HOMES LTD
16012355 · est 2024 · no financials extracted
1y
AAZJ LTD
13613065 · est 2021 · no financials extracted
4y
AB HEALTHCARE LIMITED
08389850 · est 2013 · no financials extracted
13y
ABACUS CARE & SUPPORT LIMITED
12365398 · est 2019 · no financials extracted
6y
ABBEY HOUSE DENTAL PRACTICE - RUGELEY LIMITED
06940542 · est 2009 · no financials extracted
16y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

9 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2023-03-21
Jurisdictionengland-wales
Primary SIC86210 — General medical practice activities

Registered office

Charles Rippin & Turner, Middlesex House
130 College Road
Harrow
HA1 1BQ
England

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2026-04-03OVERDUE
Last: 2025-03-20

Officers (4 active · 0 resigned)

JARWAR, Ghazala
director · ~68y · appointed 2023-03-21
View their other companies + combined net worth →
Active
MADDEN, James
director · ~44y · appointed 2023-03-21
View their other companies + combined net worth →
Active
SEN, Subir
director · ~65y · appointed 2023-03-21
View their other companies + combined net worth →
Active
VAILLANT VILA, Juan Carlos
director · ~54y · appointed 2023-03-21
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (5 total)

accounts-with-accounts-type-dormant
accounts · AA
2025-12-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-05-17
accounts-with-accounts-type-dormant
accounts · AA
2024-11-15
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-03-27
incorporation-company
incorporation · NEWINC
2023-03-21